8720 related articles for article (PubMed ID: 30877973)
1. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
[TBL] [Abstract][Full Text] [Related]
2. Impaired autophagy and APP processing in Alzheimer's disease: The potential role of Beclin 1 interactome.
Salminen A; Kaarniranta K; Kauppinen A; Ojala J; Haapasalo A; Soininen H; Hiltunen M
Prog Neurobiol; 2013; 106-107():33-54. PubMed ID: 23827971
[TBL] [Abstract][Full Text] [Related]
3. Metals, oxidative stress and neurodegenerative disorders.
Jomova K; Vondrakova D; Lawson M; Valko M
Mol Cell Biochem; 2010 Dec; 345(1-2):91-104. PubMed ID: 20730621
[TBL] [Abstract][Full Text] [Related]
4. Ginkgo biloba Extract EGb 761 and Its Specific Components Elicit Protective Protein Clearance Through the Autophagy-Lysosomal Pathway in Tau-Transgenic Mice and Cultured Neurons.
Qin Y; Zhang Y; Tomic I; Hao W; Menger MD; Liu C; Fassbender K; Liu Y
J Alzheimers Dis; 2018; 65(1):243-263. PubMed ID: 30010136
[TBL] [Abstract][Full Text] [Related]
5. Nano-Honokiol ameliorates the cognitive deficits in TgCRND8 mice of Alzheimer's disease via inhibiting neuropathology and modulating gut microbiota.
Qu C; Li QP; Su ZR; Ip SP; Yuan QJ; Xie YL; Xu QQ; Yang W; Huang YF; Xian YF; Lin ZX
J Adv Res; 2022 Jan; 35():231-243. PubMed ID: 35024199
[TBL] [Abstract][Full Text] [Related]
6. Potential Benefits of Nobiletin, A Citrus Flavonoid, against Alzheimer's Disease and Parkinson's Disease.
Nakajima A; Ohizumi Y
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31295812
[TBL] [Abstract][Full Text] [Related]
7. Impact of Insulin Degrading Enzyme and Neprilysin in Alzheimer's Disease Biology: Characterization of Putative Cognates for Therapeutic Applications.
Jha NK; Jha SK; Kumar D; Kejriwal N; Sharma R; Ambasta RK; Kumar P
J Alzheimers Dis; 2015; 48(4):891-917. PubMed ID: 26444774
[TBL] [Abstract][Full Text] [Related]
8. Geniposide ameliorates cognitive deficits by attenuating the cholinergic defect and amyloidosis in middle-aged Alzheimer model mice.
Zhao C; Zhang H; Li H; Lv C; Liu X; Li Z; Xin W; Wang Y; Zhang W
Neuropharmacology; 2017 Apr; 116():18-29. PubMed ID: 27940040
[TBL] [Abstract][Full Text] [Related]
9. The Chinese herbal formula Liuwei dihuang protects dopaminergic neurons against Parkinson's toxin through enhancing antioxidative defense and preventing apoptotic death.
Tseng YT; Chang FR; Lo YC
Phytomedicine; 2014 Apr; 21(5):724-33. PubMed ID: 24411708
[TBL] [Abstract][Full Text] [Related]
10. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL
Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884
[TBL] [Abstract][Full Text] [Related]
11. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
Chen Z; Zhong C
Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
[TBL] [Abstract][Full Text] [Related]
12. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
13. Potential Therapeutic Effects of Oleuropein Aglycone in Alzheimer's Disease.
Martorell M; Forman K; Castro N; Capó X; Tejada S; Sureda A
Curr Pharm Biotechnol; 2016; 17(11):994-1001. PubMed ID: 27455905
[TBL] [Abstract][Full Text] [Related]
14. Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.
Perfeito R; Cunha-Oliveira T; Rego AC
Free Radic Biol Med; 2013 Sep; 62():186-201. PubMed ID: 23743292
[TBL] [Abstract][Full Text] [Related]
15. Ascending monoaminergic systems alterations in Alzheimer's disease. translating basic science into clinical care.
Trillo L; Das D; Hsieh W; Medina B; Moghadam S; Lin B; Dang V; Sanchez MM; De Miguel Z; Ashford JW; Salehi A
Neurosci Biobehav Rev; 2013 Sep; 37(8):1363-79. PubMed ID: 23707776
[TBL] [Abstract][Full Text] [Related]
16. Natural products against Alzheimer's disease: Pharmaco-therapeutics and biotechnological interventions.
Dey A; Bhattacharya R; Mukherjee A; Pandey DK
Biotechnol Adv; 2017; 35(2):178-216. PubMed ID: 28043897
[TBL] [Abstract][Full Text] [Related]
17. Neurotrophic factor small-molecule mimetics mediated neuroregeneration and synaptic repair: emerging therapeutic modality for Alzheimer's disease.
Kazim SF; Iqbal K
Mol Neurodegener; 2016 Jul; 11(1):50. PubMed ID: 27400746
[TBL] [Abstract][Full Text] [Related]
18. The path from anti Parkinson drug selegiline and rasagiline to multifunctional neuroprotective anti Alzheimer drugs ladostigil and m30.
Youdim MB
Curr Alzheimer Res; 2006 Dec; 3(5):541-50. PubMed ID: 17168653
[TBL] [Abstract][Full Text] [Related]
19. Does the oxysterol 27-hydroxycholesterol underlie Alzheimer's disease-Parkinson's disease overlap?
Marwarha G; Ghribi O
Exp Gerontol; 2015 Aug; 68():13-8. PubMed ID: 25261765
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective effects of geniposide in the MPTP mouse model of Parkinson's disease.
Chen Y; Zhang Y; Li L; Hölscher C
Eur J Pharmacol; 2015 Dec; 768():21-7. PubMed ID: 26409043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
